Skip to main content

Amer Zeidan, MBBS, MHS

Associate Professor
Department of Internal Medicine, Hematology
Yale School of Medicine
Yale University
New Haven, CT

Authored Items

Ask the Expert: COMMANDS Trial Results of First-Line Luspatercept Versus Epoetin Alfa in Transfusion-Dependent Patients With Lower-Risk Myelodysplastic Syndromes
By Amer Zeidan, MBBS, MHS
Special Issues
Read More ›